diabetes header graphic


Your Hidden Weapons Of Fat Destruction:
By Shane Ellison
You have weapons of fat destruction. And you are hiding them - probably unknowingly. This explains why your waist is being overcome by enemy number one: unsightly belly fat. Are you ready to obliterate it?

As a biochemical evil-doer, belly fat slowly destroys quality of life.

Among men, it yields boobs. It keeps your soldier from standing at attention. Among women, it stores the “junk-in-the-trunk“. It smothers sex drive. It zaps life-giving energy. It disrupts mental focus.

This evil-doer is very demanding. Belly fat screams for ice-cream and soda without warning. If you don‘t yield to its desires, it holds you prisoner by making you feel edgy, light-headed, and generally pissed off until you give in.

This evil doer is a liar. Almost hourly, it tries to convince you that, “One more soda isn‘t gonna hurt you“. At night, it whispers, “Everyone in America is eating chocolate right now, you should be too“. When you wonder if you should be exercising it tries to convince you that, “Exercise is not important“.

Perhaps the most insidious characteristic of belly fat is its ability to keep you in your comfort zone -your fat comfort zone. Today, 60% of Americans are fat. Our children are following in our fat footsteps. And few people are doing anything about it. Instead, they hold tight to the myth that “carrying belly fat is genetic or a normal part of aging“. Wrong.

At 30% body fat, I reveled in my own comfort zone for an entire year before I decided to take military like action. Once I uncovered my hidden weapons of fat destruction, I descended to 11% body fat and gained about 10 lbs of muscle in 90 days and have kept it off ever since. I‘ve seen worse case scenarios do the exact same. In addition to ridding themselves and man-boobs and belly fat, some cured type II diabetes!

Forget about fad diets. Forget about fad supplements. Forget about fad drugs like Synthroid, Xenical, Meridia and the newer Accomplia that have side-effects worse than obesity. Forget about eating some exotic algae or fancy fruit drink to lose fat. If these mass produced and mass selling products were effective we wouldn?t be the fattest country in the world.

As a pharmaceutical chemist, I‘ve uncovered a trove of fat destroying weapons that would make a fat military general envious. Under the proper lifestyle and dietary circumstances the arsenal can be employed by your own body. Is Michael Moore reading?

Human Growth Hormone (hGH), Leptin, IGF-1 and Testosterone

I‘m going to spare you the biochemistry lesson. All you need to know is that in addition to being weapons of fat destruction, the above hormones are great for living young, building muscle, obtaining vibrant looking skin and ensuring that your bedroom energy is rockin‘.

Unfortunately, if you are sporting belly fat, you probably have very little of them courtesy of surging insulin levels. Insulin prevents your body from unleashing these vital fat destroyers.

The only way to get your weapons of fat destruction back on the front lines is to “increase insulin sensitivity“. Don‘t fret over the



science jargon, just keep reading.

Insulin sensitivity is the opposite of insulin resistance (type II diabetes). Sensitivity to insulin means that you won‘t have much of the fat storing hormone in your fat belly. You will live thin and slim.

Insensitivity to insulin means that your body is resistant to it and therefore does not use it up fast enough. As a result, your belly bathes in it. You get fat.. Simple right? Don‘t worry, medical doctors usually choke on their words when trying to explain it to patients (future drug eaters of America).

To increase insulin sensitivity, do the following:

1. If it tastes sweet spit it out. Don‘t complicate this one. I don‘t care about the mom-in-a-thong promoting the newest health/sports bar. I don‘t care about the dumb-jock on the verge of “roid-rage“ promoting a sweetened protein shake. And I don‘t care about how scrumptious that organic apple looks. If it tastes sweet spit it out. Maybe save it for birthdays. You‘ll be having many more by sticking to this rule.

2. Eat three meals per day and space them out by 4-5 hours. No snacking. Meals should be 50% healthy fat, 20% low glycemic carbs and 30% protein.

3. Key nutritional supplements can also be used. Among them are cinnamon (2-6 grams daily) and banaba leaf containing 1% corosolic acid (50-250 mg daily). The best time to use is 30-60 minutes prior to meals. These supplements are safer and more effective than any prescription drug. In fact, using “combinatorial chemistry“, drug labs are trying to make a synthetic copy-cat of both as we speak - they‘ve been failing for years.

4. Expose that white belly to God‘s healing rays! Showering 85% of your body to sunlight for 20 - 45 minutes three to five times per week will increase insulin sensitivity while controlling sugar cravings. Skin damaging sunscreen is not allowed.

5. Use my free, insulin controlling workout (sign up for my free Secret Cures eLetter above) to ensure that you pack on that dormant, sexy muscle.

Some readers will have a momentary lapse in judgment. They will continue to hide their weapons of fat destruction and instead choose to be a “drug eater of America“. This is futile and dangerous. Not a single prescription drug address - insulin sensitivity. This is the primary reason none of them reverse obesity, insulin resistance or type II diabetes. They just mask symptoms. This is a stark reminder that Mother Nature provides the best medicine.

Cute, Dimply Fat Eradicated

The above tactics will bring hGH, leptin, IGF-1 and testosterone front and center. Insulin will decrease (along with blood sugar) and your weapons of fat destruction will emerge. No matter how cute, squishy and dimply your fat might be, it will be eradicated. The shock and awe that follows will leave your peers secretly wondering, “Wow! What did they do to get rid of all that unsightly belly fat?“

But, But, But?

“But, my doctor told me to stay on my med‘s and that they would control my weight, am I supposed to get off my drugs?“

“But, I heard that Xango would cure my obesity and my toe fungus. Are you saying to stop drinking it?“

“But, I‘ve been overweight my whole life, it runs in my family.“

Stop! Don‘t say another word. Your fat cells are eating your brain. Use your hidden weapons of fat destruction before your quality of life is destroyed.

Article Source: http://www.ArticleJoe.com

Shane “The People‘s Chemist“ Ellison has an MS in organic chemistry and has first hand experience in drug design and synthesis. He is an internationally recognized authority on therapeutic nutrition and the author of Health Myths Exposed, The Hidden Truth About Cholesterol-Lowering Drugs and The AM-PM Fat Loss Discovery. Get a 10% discount on these products by visiting www.thepeopleschemist.com/foundation.html.




Here are some more diabetes articles...

A Refreshing Way To Avoid Diabetes?
By Robert Barr
It appears that decaffeinated coffee has been linked to lowering your risk of type 2 diabetes, according to a report in a recent issue of Archives of Internal Medicine, a JAMA/Archives journal. It Read more...
How Does Whey Protein Affect My Body?
By hamoon
Whey protein is available in supplement form and whey protein contains many positive health benefits within its whey protein powder formula. Derived originally from whole milk, whey protein is Read more...

Efficacy of Adding Sitagliptin or Pioglitazone to T2DM Insufficiently Controlled With Metformin and Sulfonylurea
<b>Condition</b>:   Type 2 Diabetes<br/><b>Interventions</b>:   Drug: Sitagliptin;   Drug: pioglitazone<br/><b>Sponsor</b>:   Mackay Memorial Hospital<br/><b>Recruiting</b> - verified September 2010
Benefit/Risk Evaluation of Insuman Implantable Versus Insuplant Using Medtronic MiniMed Implantable Pump System in Patients With Type 1 Diabetes
<b>Condition</b>:   Diabetes Mellitus, Type 1<br/><b>Interventions</b>:   Drug: HUMAN INSULIN (BIOSYNTHETIC);   Drug: Insuplant<br/><b>Sponsor</b>:   Sanofi-Aventis<br/><b>Not yet recruiting</b> - verified September 2010
Efficacy and Safety of Linagliptin (BI 1356) in Black/African Americans With Type 2 Diabetes With a MTT Sub-study
<b>Condition</b>:   Diabetes Mellitus, Type 2<br/><b>Interventions</b>:   Drug: Placebo;   Drug: Linagliptin<br/><b>Sponsor</b>:   Boehringer Ingelheim Pharmaceuticals<br/><b>Not yet recruiting</b> - verified September 2010
Effect of Formoterol on the Counterregulatory Hormonal Response to Hypoglycemia
<b>Condition</b>:   Type 1 Diabetes<br/><b>Intervention</b>:   Drug: Formoterol<br/><b>Sponsors</b>:   Yale University;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)<br/><b>Recruiting</b> - verified September 2010
Insulin Administration Plus a Telemedicine System (Diabetes Interactive Diary - DID) vs Insulin Plus Common Practice
<b>Condition</b>:   Type 1 Diabetes<br/><b>Intervention</b>:   Device: Diabetes Interactive Diary (DID)<br/><b>Sponsors</b>:   Consorzio Mario Negri Sud;   Sanofi-Aventis;   LifeScan<br/><b>Recruiting</b> - verified September 2010
Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Patients With Type 1 Diabetes Mellitus
<b>Condition</b>:   Diabetes Mellitus, Type 1<br/><b>Intervention</b>:   Drug: Insulin LISPRO<br/><b>Sponsor</b>:   Halozyme Therapeutics<br/><b>Recruiting</b> - verified September 2010
Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Patients With Type 2 Diabetes Mellitus
<b>Condition</b>:   Diabetes Mellitus, Type II<br/><b>Intervention</b>:   Drug: Insulin LISPRO<br/><b>Sponsor</b>:   Halozyme Therapeutics<br/><b>Recruiting</b> - verified September 2010
Comparison of NN1250 Versus Insulin Glargine in Subjects With Type 2 Diabetes: An Extension Trial to NN1250-3579
<b>Condition</b>:   Diabetes Mellitus, Type 2<br/><b>Interventions</b>:   Drug: NN1250;   Drug: insulin glargine<br/><b>Sponsor</b>:   Novo Nordisk<br/><b>Not yet recruiting</b> - verified August 2010
Comparison of NN1250 With Insulin Glargine Plus Insulin Aspart With or Without Metformin and With/Without Pioglitazone in Type 2 Diabetes: An Extension Trial to NN1250-3582
<b>Condition</b>:   Diabetes Mellitus, Type 2<br/><b>Interventions</b>:   Drug: NN1250;   Drug: insulin glargine;   Drug: insulin aspart<br/><b>Sponsor</b>:   Novo Nordisk<br/><b>Not yet recruiting</b> - verified August 2010
BI 10773 Dose Finder Study in Japanese Patients With Type 2 Diabetes Mellitus
<b>Condition</b>:   Diabetes Mellitus, Type 2<br/><b>Interventions</b>:   Drug: BI 10773;   Drug: BI 10773;   Drug: BI 10773;   Drug: BI 10773;   Drug: Placebo<br/><b>Sponsor</b>:   Boehringer Ingelheim Pharmaceuticals<br/><b>Not yet recruiting</b> - verified August 2010
Risk Factors for Low Lymphocyte Count in Patients With Type 2 Diabetes
<b>Condition</b>:   Diabetes Mellitus, Type 2<br/><b>Intervention</b>:   <br/><b>Sponsors</b>:   Bristol-Myers Squibb;   AstraZeneca<br/><b>Active, not recruiting</b> - verified August 2010
A Study of OPC-262 in Patients With Type 2 Diabetes
<b>Condition</b>:   Diabetes, Type 2<br/><b>Intervention</b>:   Drug: OPC-262<br/><b>Sponsor</b>:   Otsuka Pharmaceutical Co., Ltd.<br/><b>Recruiting</b> - verified August 2010
Glycemic Holter Study (Continuous Glucose Monitoring) -
<b>Condition</b>:   Type 2 Diabetes Mellitus<br/><b>Interventions</b>:   Drug: Vildagliptin;   Drug: Sitagliptin<br/><b>Sponsor</b>:   Novartis<br/><b>Recruiting</b> - verified August 2010
Psychosocial Interventions in the Treatment of Youth With Type 1 Diabetes Mellitus
<b>Condition</b>:   Diabetes Mellitus<br/><b>Intervention</b>:   Behavioral: psychosocial intervention<br/><b>Sponsor</b>:   Assaf-Harofeh Medical Center<br/><b>Recruiting</b> - verified August 2010
Bioequivalence Study of the Fixed Dose Combination of 5 mg Saxagliptin and 500 mg Metformin XR Tablet (Manufactured in Mt Vernon, IN) Relative to 5 mg Saxagliptin Tablet and 500 mg Metformin XR Tablet (Manufactured in Evansville, IN)
<b>Condition</b>:   Diabetes Mellitus<br/><b>Interventions</b>:   Drug: saxagliptin;   Drug: metformin XR;   Drug: saxagliptin + metformin XR (FDC tablet)<br/><b>Sponsor</b>:   Bristol-Myers Squibb<br/><b>Completed</b> - verified August 2010
Bioequivalence Study of the Fixed Dose Combination of 5 mg Saxagliptin/1000 mg Metformin XR (Manufactured in Mt Vernon, IN) Relative to 5 mg of Onglyza and 2 × 500 mg Glucophage XR
<b>Condition</b>:   Diabetes Mellitus<br/><b>Interventions</b>:   Drug: saxagliptin;   Drug: Glucophage XR;   Drug: saxagliptin + metformin XR (FDC tablet)<br/><b>Sponsor</b>:   Bristol-Myers Squibb<br/><b>Completed</b> - verified August 2010
A Study in Patients With Type 2 Diabetes Mellitus (AWARD-4)
<b>Condition</b>:   Diabetes Mellitus, Type 2<br/><b>Interventions</b>:   Drug: Insulin Glargine;   Drug: LY2189266<br/><b>Sponsor</b>:   Eli Lilly and Company<br/><b>Not yet recruiting</b> - verified August 2010
Comparison of NN1250 Plus Insulin Aspart With Insulin Detemir Plus Insulin Aspart in Type 1 Diabetes: An Extension Trial to NN1250-3585
<b>Condition</b>:   Diabetes Mellitus, Type 1<br/><b>Interventions</b>:   Drug: NN1250;   Drug: insulin detemir (Levemir®);   Drug: insulin aspart<br/><b>Sponsor</b>:   Novo Nordisk<br/><b>Not yet recruiting</b> - verified August 2010
Exploratory Study to Evaluate the Efficacy of Androxal in Controlling Blood Glucose in Men With Type-2 Diabetes Mellitus and Secondary Hypogonadism or Adult-Onset Idiopathic Hypogonadotropic Hypogonadism
<b>Conditions</b>:   Type 2 Diabetes Mellitus;   Secondary Hypogonadism<br/><b>Interventions</b>:   Drug: Placebo;   Drug: enclomiphene citrate<br/><b>Sponsor</b>:   Repros Therapeutics Inc.<br/><b>Not yet recruiting</b> - verified August 2010
Subcutaneous Administration of Teplizumab in Adults With Type 1 Diabetes
<b>Condition</b>:   Type 1 Diabetes Mellitus<br/><b>Intervention</b>:   Drug: teplizumab or placebo<br/><b>Sponsors</b>:   MacroGenics;   Eli Lilly and Company<br/><b>Recruiting</b> - verified August 2010
Safety and Efficacy of Sitagliptin Compared With Glimepiride in Elderly Patients With Type 2 Diabetes Mellitus (0431-251)
<b>Condition</b>:   Type 2 Diabetes Mellitus<br/><b>Interventions</b>:   Drug: sitagliptin phosphate;   Drug: Glimepiride<br/><b>Sponsor</b>:   Merck<br/><b>Not yet recruiting</b> - verified August 2010
Four-Hour Evaluation of a Medical Food in Subjects With Type 2 Diabetes
<b>Condition</b>:   Diabetes Mellitus, Type 2<br/><b>Interventions</b>:   Other: Experimental nutritional formula #M979;   Other: Standard food<br/><b>Sponsor</b>:   Abbott Nutrition<br/><b>Completed</b> - verified July 2010
Modulation of Free Fatty Acids in Heart Failure Patients With Diabetes: "Effect on Left Ventricular Function"
<b>Conditions</b>:   Heart Failure;   Diabetes<br/><b>Interventions</b>:   Other: Metabolic substrate modulation;   Other: metabolic substrate modulation<br/><b>Sponsors</b>:   University of Aarhus;   Danish Heart Foundation<br/><b>Recruiting</b> - verified August 2010
Study of Two Oral Formulations of LX4211 in Patients With Type 2 Diabetes Mellitus
<b>Condition</b>:   Type 2 Diabetes Mellitus<br/><b>Interventions</b>:   Drug: 300 mg LX4211 (150 mg tablets);   Drug: 300 mg LX4211 (50 mg tablets);   Drug: 300 mg LX4211 (liquid)<br/><b>Sponsor</b>:   Lexicon Pharmaceuticals<br/><b>Not yet recruiting</b> - verified August 2010
Hormones and Sexual Function Predict Outcomes in Revascularized Men With Diabetes
<b>Conditions</b>:   Androgen Deficiency (AD);   Erectile Dysfunction (ED);   Development of Predictive Cardiovascular/Cerebrovascular AE<br/><b>Intervention</b>:   <br/><b>Sponsors</b>:   Mount Sinai School of Medicine;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)<br/><b>Recruiting</b> - verified August 2010
A Multi-professional Team Intervention on Physical Activity Referrals in Primary Care Patients With Cardiovascular Risk Factors?the Dalby Lifestyle Intervention Cohort (DALICO) Study
<b>Condition</b>:   Motivation for Physical Activity<br/><b>Interventions</b>:   Behavioral: Multi-professional team intervention with PAR, lifestyle brochure;   Behavioral: Ordinary recommendations on health behaviours, lifestyle brochure<br/><b>Sponsors</b>:   Region Skane;   Swedish Council for Working Life and Social Research<br/><b>Not yet recruiting</b> - verified August 2010
Exercise Program Combined or Not With Nutritional intErvention in Adults With tyPe 2 Diabetes
<b>Conditions</b>:   Overweight;   Obesity;   Type 2 Diabetes<br/><b>Interventions</b>:   Behavioral: Caloric restriction;   Behavioral: Diet intervention and structured exercise training program<br/><b>Sponsor</b>:   Institut de Recherches Cliniques de Montreal<br/><b>Not yet recruiting</b> - verified August 2010
A 12-week, Multicentric Study to Evaluate the Safety and Efficacy of Bisoprolol in Diabetic and Hypertensive Filipinos
<b>Condition</b>:   Hypertension<br/><b>Intervention</b>:   Drug: Bisoprolole<br/><b>Sponsor</b>:   Merck KGaA<br/><b>Recruiting</b> - verified August 2010
Safety and Efficacy of Chlorthalidone + Amiloride to Elderly Patients Treatment With Arterial Hypertension
<b>Condition</b>:   Arterial Hypertension<br/><b>Interventions</b>:   Drug: Chlorthalidone 25 mg + amiloride hydrochloride 5 mg;   Drug: Higroton® Laboratório Novartis<br/><b>Sponsor</b>:   Eurofarma Laboratorios Ltda<br/><b>Not yet recruiting</b> - verified August 2010
n-3 Polyunsaturated Fatty Acids (PUFA) Supplementation in Young Women With Polycystic Ovary Syndrome (PCOS)
<b>Condition</b>:   Polycystic Ovary Syndrome<br/><b>Intervention</b>:   Dietary Supplement: LC n-3 PUFA (fish oil) Supplement<br/><b>Sponsors</b>:   The Adelaide and Meath Hospital;   University College Dublin<br/><b>Completed</b> - verified July 2008